Cert

EU-MDR Certification: Meeting the European Standard in Hyperbaric Oxygen Therapy

HPO.TECH has completed the transition of its hyperbaric chamber systems from the EU Medical Device Directive to the EU Medical Device Regulation, becoming the first dedicated hyperbaric oxygen therapy manufacturer to do so. For anyone who buys, operates, or is treated in a hyperbaric chamber, this development is important, as it allows you to operate our devices legally in a medical setting all around Europe.

What is the EU-MDR certification?

The Medical Device Regulation, formally Regulation (EU) 2017/745, is the law that governs medical devices sold in the European Union. It replaced the Medical Device Directive (MDD, 93/42/EEC), which had been the reference framework since the 1990s. MDR now sets the requirements every device must meet to carry a CE mark and be placed on the European market.

The shift from a directive to a regulation means we now have a singular standard across the European Union, as opposed to variations in the local legislation of each member state. A directive lets countries translate the rules as they see fit. A regulation applies directly and identically across every member state. 

Why is the regulation better than the directive?

MDR was written in response to a straightforward criticism of the old system: a device could clear the bar at market entry and then face relatively little scrutiny afterward. The regulation closes that gap in three main ways:

  • It asks for stronger clinical evidence. A manufacturer has to demonstrate, with data appropriate to the device and its intended purpose, that the device performs as claimed and is safe to use.
  • It asks for traceability. Every unit carries a Unique Device Identifier and is registered in EUDAMED, the European database, so a specific chamber can be tracked from factory to clinic.
  • And it asks for continuous post-market surveillance. The manufacturer’s duty does not end at the sale. It continues, with structured monitoring and reporting, for as long as the device is in clinical use.
Trust

The move to EU-MDR has been one of the harder passages in recent European medtech.

The requirements are heavier, the notified bodies that assess devices are fewer and more stretched than before, and the technical documentation involved is substantial. To keep compliant devices from dropping off the market during the changeover, EU lawmakers extended the deadlines for legacy MDD certificates to 2027 and 2028. Many manufacturers are still working through that extended runway.

Completing the transition now, rather than relying on the extra time, indicates that a manufacturer’s systems already met the regulation’s requirements. For us at HPO.TECH, that’s the point. Our chambers did not have to be reworked to pass. They were engineered to a standard the regulation has since made mandatory.

What does this mean, in practice, for HPO.TECH?

Beyond the European Union, MDR certification also expands HPO.TECH’s international regulatory reach. Together with a Certificate of Free Sale, it supports streamlined registration pathways across much of Southeast Asia, the Gulf region, Latin America, Africa, and EU-aligned European markets, including countries such as Malaysia, Indonesia, Pakistan, Egypt, Mexico, Colombia, Chile, Switzerland, and the Western Balkans.

While local registration remains necessary, MDR serves as the principal reference standard for market access in many of these jurisdictions.

Where does MDR fit in HPO.TECH’s certification set?

MDR joins a broader set of clearances the company holds, among them ISO 13485 for medical-device quality management, the Pressure Equipment Directive (PED 2014/68/EU), ASME PVHO certification for pressure vessels for human occupancy, UKCA marking for the United Kingdom, ASME U-Stamp, SFDA, UAE MOH+EDE, Medsafe New Zealand, Thai FDA, GHANA FDA, and ISO 9001. Moreover, the company is in the process of obtaining USA FDA, Philippines FDA, Vietnam DMEC, Hong Kong MDACS, Mexico COFEPRIS, Singapore HSA, Taiwan FDA, and Japan PMDA.

Read together, they describe a device evaluated and certified as both a medical product and a pressure system, in many countries and jurisdictions. For a field still moving through the EU-MDR transition, HPO.TECH reaching the far side of it early is a marker of where its engineering already stood.

Trust
Andrei Nico

With a fascination for hyperbaric oxygen therapy, Andrei combines expert insights, research-driven content, real-world applications and case studies to uncover HBOT's potential for performance, recovery, and longevity.

Hyperbaric Oxygen Chamber
Monoplace vs Multiplace Hyperbaric Chamber: Configuration & Cost ComparisonKnowledge Base

Monoplace vs Multiplace Hyperbaric Chamber: Configuration & Cost Comparison

HPO TECHHPO TECHAugust 3, 2026
zeugma panorama whx dubai
Decompression Chamber vs Hyperbaric Chamber: Terminology for BuyersKnowledge Base

Decompression Chamber vs Hyperbaric Chamber: Terminology for Buyers

HPO TECHHPO TECHJuly 1, 2026
zeugma-hyperbaric-chamber
Events agenda 2025: The ZEUGMA hyperbaric chamber tour-de-force on the global stageDeep DiveZEUGMA

Events agenda 2025: The ZEUGMA hyperbaric chamber tour-de-force on the global stage

Andrei NicoAndrei NicoJuly 30, 2025

Leave a Reply